Clinical trial
Combination Chemotherapy in Treating Children With Anaplastic Large Cell…
NCT00006455 · Gustave Roussy, Cancer Campus, Grand Paris, Other · Completed
Key facts
| NCT number | NCT00006455 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) |
| Official title | International Protocol for the Treatment of Childhood Anaplastic Large Cell Lymphoma |
| Acronym | ALCL 99 |
| Lead sponsor | Gustave Roussy, Cancer Campus, Grand Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | cyclophosphamide, cytarabine, dexamethasone, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, methotrexate, therapeutic hydrocortisone, vinblastine sulfate |
| Enrollment | 885 |
| Start date | Nov 26, 1999 |
| Primary completion | Jan 12, 2009 |
| Completion | Sep 3, 2020 |
| First posted | Jan 27, 2003 |
| Last update posted | May 31, 2022 |
| Countries | Austria, Belgium, France, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: